Abstract:The study of Lesch-Nyhan-diseased (LND) human brain is crucial for understanding how mutant hypoxanthine-phosphoribosyltransferase (HPRT) might lead to neuronal dysfunction. Since LND is a rare, inherited disorder caused by a deficiency of the enzyme HPRT, human neural stem cells (hNSCs) that carry this mutation are a precious source for delineating the consequences of HPRT deficiency and for developing new treatments. In our study we have examined the effect of HPRT deficiency on the differentiation of neuron… Show more
“…Transcriptional aberrations in a number of genes have been described in the HPRT knockout mice, which might play a role in the disease phenotype [119]. Such novel hypothesis has recently been confirmed by studies in HPRTdeficient cell models [120,121] and in HPRT-deficient human neural stem cells [122]. Aberrant expression of several vital transcription factors involved in DA neuron development and in pan-neuronal differentiation has been demonstrated in cultured HPRT-deficient human teratocarcinoma NT cells (NT2), providing direct experimental evidence for aberrant neurogenesis in HPRT deficiency.…”
“…Dopaminergic dysfunction in specific regions of the brain (basal ganglia) was ascertained to underlie the neurodevelopmental manifestations and recent findings [120][121][122] support an unexpected interference of HPRT deficiency on unrelated gene expression. Nevertheless, the molecular mechanism by which this occurs is still unveiled and we report all the previous and recent observations since at present no hypothesis can be completely ruled out.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, disruption of purine levels is known to have an important influence on neuronal differentiation in other cells [123]. Altered expression of several transcription factors and DA markers was found in human neural stem cells (hNSCs) isolated from human LNS fetal brain, providing direct experimental evidence for aberrant neurogenesis in LNS [122]. Thus a "housekeeping gene" such as HPRT, merely considered to have important metabolic functions, might also play a vital role in some pathways of mammalian neurogenesis.…”
Purines and pyrimidines, regarded for a long time only as building blocks for nucleic acid synthesis and intermediates in the transfer of metabolic energy, gained increasing attention since genetically determined aberrations in their metabolism were associated clinically with various degrees of mental retardation and/or unexpected and often devastating neurological dysfunction. In most instances the molecular mechanisms underlying neurological symptoms remain undefined. This suggests that nucleotides and nucleosides play fundamental but still unknown roles in the development and function of several organs, in particular central nervous system. Alterations of purine and pyrimidine metabolism affecting brain function are spread along both synthesis (PRPS, ADSL, ATIC, HPRT, UMPS, dGK, TK), and breakdown pathways (5NT, ADA, PNP, GCH, DPD, DHPA, TP, UP), sometimes also involving pyridine metabolism. Explanations for the pathogenesis of disorders may include both cellular and mitochondrial damage: e.g. deficiency of the purine salvage enzymes hypoxanthine-guanine phosphoribosyltransferase and deoxyguanosine kinase are associated to the most severe pathologies, the former due to an unexplained adverse effect exerted on the development and/or differentiation of dopaminergic neurons, the latter due to impairment of mitochondrial functions. This review gathers the presently known inborn errors of purine and pyrimidine metabolism that manifest neurological syndromes, reporting and commenting on the available hypothesis on the possible link between specific enzymatic alterations and brain damage. Such connection is often not obvious, and though investigated for many years, the molecular basis of most dysfunctions of central nervous system associated to purine and pyrimidine metabolism disorders are still unexplained.
“…Transcriptional aberrations in a number of genes have been described in the HPRT knockout mice, which might play a role in the disease phenotype [119]. Such novel hypothesis has recently been confirmed by studies in HPRTdeficient cell models [120,121] and in HPRT-deficient human neural stem cells [122]. Aberrant expression of several vital transcription factors involved in DA neuron development and in pan-neuronal differentiation has been demonstrated in cultured HPRT-deficient human teratocarcinoma NT cells (NT2), providing direct experimental evidence for aberrant neurogenesis in HPRT deficiency.…”
“…Dopaminergic dysfunction in specific regions of the brain (basal ganglia) was ascertained to underlie the neurodevelopmental manifestations and recent findings [120][121][122] support an unexpected interference of HPRT deficiency on unrelated gene expression. Nevertheless, the molecular mechanism by which this occurs is still unveiled and we report all the previous and recent observations since at present no hypothesis can be completely ruled out.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, disruption of purine levels is known to have an important influence on neuronal differentiation in other cells [123]. Altered expression of several transcription factors and DA markers was found in human neural stem cells (hNSCs) isolated from human LNS fetal brain, providing direct experimental evidence for aberrant neurogenesis in LNS [122]. Thus a "housekeeping gene" such as HPRT, merely considered to have important metabolic functions, might also play a vital role in some pathways of mammalian neurogenesis.…”
Purines and pyrimidines, regarded for a long time only as building blocks for nucleic acid synthesis and intermediates in the transfer of metabolic energy, gained increasing attention since genetically determined aberrations in their metabolism were associated clinically with various degrees of mental retardation and/or unexpected and often devastating neurological dysfunction. In most instances the molecular mechanisms underlying neurological symptoms remain undefined. This suggests that nucleotides and nucleosides play fundamental but still unknown roles in the development and function of several organs, in particular central nervous system. Alterations of purine and pyrimidine metabolism affecting brain function are spread along both synthesis (PRPS, ADSL, ATIC, HPRT, UMPS, dGK, TK), and breakdown pathways (5NT, ADA, PNP, GCH, DPD, DHPA, TP, UP), sometimes also involving pyridine metabolism. Explanations for the pathogenesis of disorders may include both cellular and mitochondrial damage: e.g. deficiency of the purine salvage enzymes hypoxanthine-guanine phosphoribosyltransferase and deoxyguanosine kinase are associated to the most severe pathologies, the former due to an unexplained adverse effect exerted on the development and/or differentiation of dopaminergic neurons, the latter due to impairment of mitochondrial functions. This review gathers the presently known inborn errors of purine and pyrimidine metabolism that manifest neurological syndromes, reporting and commenting on the available hypothesis on the possible link between specific enzymatic alterations and brain damage. Such connection is often not obvious, and though investigated for many years, the molecular basis of most dysfunctions of central nervous system associated to purine and pyrimidine metabolism disorders are still unexplained.
“…Engrailed proteins act as axon guidance factors, regulating mRNA translation in growth cones [64], and en1 has been detected in dendrites of dopaminergic neurons [65]. Abnormal neurite outgrowth was also observed in a recent study that used human neural stem cells (NSC) carrying LND mutations to generate dopaminergic neurons in vitro [66]. HPRT-deficient NSCs were found to exhibit reduced neurogenesis even after only 3 days of differentiation.…”
The majority of studies investigating the molecular pathogenesis and cell biology underlying dystonia have been performed in individuals with primary dystonia. This includes monogenic forms such as DYT1and DYT6 dystonia, and primary focal dystonia which is likely to be multifactorial in origin. In recent years there has been renewed interest in non-primary forms of dystonia including the dystonia-plus syndromes and heredodegenerative disorders. These are caused by a variety of genetic mutations and their study has contributed to our understanding of the neuronal dysfunction that leads to dystonia These findings have reinforced themes identified from study of primary dystonia including abnormal dopaminergic signalling, cellular trafficking and mitochondrial function. In this review we highlight recent advances in the understanding of the dystonia-plus syndromes and heredodegenerative dystonias.
“…[12–15] Transcription factors, such as engrailed, [10] have been shown to be dysregulated in HPRT-deficient neuronal cells, leading to impaired dopaminergic neurotransmission or early neurodevelopmental problems. [10,16,17] …”
Lesch-Nyhan disease (LND) is an X-linked metabolic disease caused by various mutations in the gene HPRT1 encoding an enzyme of purine metabolism, hypoxanthine guanine phosphoribosyltransferase (HPRT). In its most severe form, LND patients suffer from overproduction of uric acid along with neurological or behavioural difficulties including self-injurious behaviours. To gain more insight into pathogenesis, we compared the transcriptome from human LND fibroblasts to normal human fibroblasts using a microarray with 60,000 probes corresponding to the entire human genome. Using stringent criteria, we identified 25 transcripts whose expression was significantly different between LND and control cells. These genes were confirmed by quantitative RT-PCR to be dysregulated in LND cells. Moreover, bioinformatic analysis of microarray data using gene ontology (GO) highlighted clusters of genes displaying biological processes most significantly affected in LND cells. These affected genes belonged to specific processes such as cell cycle and cell-division processes, metabolic and nucleic acid processes, demonstrating the specific nature of the changes and providing new insights into LND pathogenesis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.